To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
0.08+68.89% from last year
Operating profits
-0.50-129.49% from last year
Net income
-0.71-162.13% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Net worth10.7111.3717.3822.2432.6743.6452.4358.87174.44
Fixed assets6.366.4511.4021.3231.2041.1050.9761.16140.95
Debt14.0013.1112.0111.3310.339.139.8516.0015.28
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating--0.100.010.14-1.74-0.630.026.47
Investing --0.01-0.10-0.03-1.743.05--6.47
Financing -----0.20--2.37--

Financial ratios

Profitability ratiosinfo2
ROA-0.46%
ROE-5.94%
ROCE-2.1%
EPS-0.09%
Net profit margin-279.05%
Operating profit margin-180.33%
Dividend per share
Operational ratiosinfo2
Quick ratio0.1%
Current ratio0.1%
Interest coverage-3.7%
Assets turnover
Debt to equity1.31%
Valuation ratiosinfo2
P/E ratio
P/B ratio3.62%
Dividend yield
EV/EBITDA
Transgene Biotek Ltd (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs for Sustained Release.Biogeneries-Tacrolimus and Pegylated EPO.Human Vaccines-Meningococcal Meningitis Universal Meningococcal Meningitis Haemophilus Influenza B-Hib DTP+Hib+Hep B Combination etc.Cancer Drugs/Oncology-Multiple Myeloma Barrett's Esophageal Cancer Colon Cancer and Breast Cancer..The company also in the business segment of Diagnostics CRO Services.
personal

Grow your wealth with more research recommendations

+91